Get startedLog in
    Picture of Werewolf Therapeutics logo

    HOWL — Werewolf Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Werewolf Therapeutics Q3 basic EPS USD -0.23

    Picture of Werewolf Therapeutics logoWerewolf Therapeutics
    14/11/2023 21:30
    Nov 14 (Reuters) - Werewolf Therapeutics Q3 basic EPS USD -0.23.
* Q3 operating expenses USD 15.148 million
* Q3 collaboration revenue USD 5.897 million
* Q3 net income USD -8.285 million
* Q3 operating income USD -9.251 million

    Recent news on Werewolf Therapeutics

    See all news